Drug companies claim that off-label drug promotion is protected by freedom of speech.

Continuous monitoring of pharma products with an innovative matchbox-sized laser

Several companies are faced with recall woes thanks to insects, dodgy closures and broken tablets.

Porous shells - inspired by sea urchins - help defend biomacromolecules from the outside world.

Engineered E. coli colonies could be trump cards in the war against drug resistance.

The first US biosimilar - Zarxio from Sandoz - has been cleared for market. But the judges say it wasn't an easy decision.

After 28 years of R&D at GSK, the world has its first malaria vaccine.

A new mathematical model aims to improve drugs for cancer, viruses and bacteria.

A round-up of the latest expansion plans and new facilities as building fever grips the industry

Could existing drugs be repurposed as a shortcut to treating Ebola?